Value of body fat mass measured by bioelectrical impedance analysis in predicting abnormal blood pressure and abnormal glucose metabolism in children.
- Author:
Hai-Bo LI
1
;
Hong CHENG
;
Dong-Qing HOU
;
Ai-Yu GAO
;
Zhong-Xin ZHU
;
Zhao-Cang YU
;
Hong-Jian WANG
;
Xiao-Yuan ZHAO
;
Pei XIAO
;
Gui-Min HUANG
;
Jie MI
Author Information
1. Department of Epidemiology, Capital Institute of Pediatrics, Beijing 100020, China. mijie@bch.com.cn.
- Publication Type:Journal Article
- MeSH:
Adipose Tissue;
Adolescent;
Blood Pressure;
Body Composition;
Body Mass Index;
Child;
Electric Impedance;
Female;
Glucose;
Humans;
Male
- From:
Chinese Journal of Contemporary Pediatrics
2020;22(1):17-23
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the value of body fat mass measured by bioelectrical impedance analysis (BIA) in predicting abnormal blood pressure and abnormal glucose metabolism in children.
METHODS:Stratified cluster sampling was used to select the students aged 6-16 years, and a questionnaire survey and physical examination were performed. The BIA apparatus was used to measure body fat mass. Body mass index (BMI), body fat mass index (FMI), and fat mass percentage (FMP) were calculated. Fasting blood glucose level were measured.
RESULTS:A total of 14 293 children were enrolled, among whom boys accounted for 49.89%. In boys and girls, the percentile values (P, P, P, P, P, P, P, P) of FMI and FMP fitted by the LMS method were taken as the cut-off values. Based on the receiver operating characteristic curve analysis, the P values with a better value in predicting abnormal blood pressure and blood glucose metabolism were selected as the cut-off values for excessive body fat. When FMI or FMP was controlled below P, the incidence of abnormal blood pressure or abnormal glucose metabolism may be decreased in 8.25%-43.24% of the children.
CONCLUSIONS:The evaluation of obesity based on FMI and FMP has a certain value in screening for hypertension and hyperglycemia in children, which can be further verified in the future prevention and treatment of obesity and related chronic diseases in children.
